Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Anica Hoza"'
Autor:
Cătălina Dănilă, Ioana Alexandra Cardos, Andrea Pop-Crisan, Felicia Marc, Anica Hoza, Razvan Chirla, Andrei Pascalău, Calin Magheru, Simona Cavalu
Publikováno v:
Life, Vol 12, Iss 12, p 2096 (2022)
Helicobacter pylori (H. pylori) infects about half of the world’s population and can lead to premalignant lesions and gastric cancer. Updated data about the correlation of histopathological diagnostics with endoscopic diagnostics are scarce. The ob
Externí odkaz:
https://doaj.org/article/2f443ce49e5e4ecf8633c7024469a006
Autor:
Sorina Magheru, Calin Magheru, Florin Maghiar, Liliana Sachelarie, Felicia Marc, Corina Maria Moldovan, Laura Romila, Anica Hoza, Dorina Maria Farcas, Irina Gradinaru, Loredana Liliana Hurjui
Publikováno v:
Biology, Vol 11, Iss 8, p 1189 (2022)
(1) Background: Myocardial infarction was, until recently, recognized as a major coronary event, often fatal, with major implications for survivors. According to some authors, diabetes mellitus is an important atherogenic risk factor with cardiac det
Externí odkaz:
https://doaj.org/article/a6b87d8c7fa143378e85fd7ee4229412
Autor:
Felicia Marc, Corina Moldovan, Anica Hoza, Patricia Restea, Liliana Sachelarie, Laura Ecaterina Romila, Corina Suteu, Dorina Maria Farcas
Publikováno v:
Biology, Vol 11, Iss 1, p 13 (2021)
(1) Background: The antiviral treatment for COVID-19 disease started to be largely used in 2020 and has been found to be efficient, although it is not specific for SARS-CoV-2 virus. There were some concerns that it may produce liver damage or other s
Externí odkaz:
https://doaj.org/article/d56e7dede0fa49479250276ca00db9f9
Autor:
Felicia Marc, Corina Moldovan, Anica Hoza, Patricia Restea, Liliana Sachelarie, Laura Ecaterina Romila, Corina Suteu, Dorina Maria Farcas
Publikováno v:
Biology, Vol 11, Iss 13, p 13 (2022)
Biology
Biology; Volume 11; Issue 1; Pages: 13
Biology
Biology; Volume 11; Issue 1; Pages: 13
Simple Summary In order to treat COVID-19 disease, various drugs have been used as repurposed drugs, because no drug directly targets against the SARS-CoV-2 virus. The aim of this study was to evaluate the relationship between the drugs used for COVI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb625529c0701b6823f1c7d1a489e423
https://www.mdpi.com/2079-7737/11/1/13
https://www.mdpi.com/2079-7737/11/1/13
Autor:
Felicia Marc, Corina Maria Moldovan, Anica Hoza, Sorina Magheru, Gabriela Ciavoi, Dorina Maria Farcas, Liliana Sachelarie, Gabriela Calin, Laura Romila, Daniela Damir, Alexandru Gratian Naum
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 10; Pages: 2945
(1) Background: In patients hospitalized with COVID-19 pneumonia, especially moderate and severe forms, a cytokine storm may occur, characterized by the worsening of symptoms and the alteration of biological parameters on days 8–12 of the disease.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9daddb25d9a167b79727944b38d085f
https://doi.org/10.3390/jcm11102945
https://doi.org/10.3390/jcm11102945
Autor:
Anica Hoza
Publikováno v:
FARMACIA. 66:652-657
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3602900f1e5d7cc80c5698e53e5ecbe6
https://doi.org/10.31925/farmacia.2018.4.14
https://doi.org/10.31925/farmacia.2018.4.14